{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:42:30Z","timestamp":1788183750182,"version":"build-2803163510"},"reference-count":125,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI168362"],"award-info":[{"award-number":["R01 AI168362"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The continued emergence of viral pathogens underscores the need for novel antiviral therapeutics with improved efficacy. Small-molecule inhibitors of viral entry are attractive antiviral agents because they block the virus at its earliest step, preventing the virus from entering host cells and causing downstream damage. Some of the viruses of greatest concern for human health, such as human immunodeficiency virus, respiratory syncytial virus, influenza virus, Ebola virus, severe acute respiratory syndrome coronavirus 2, and Lassa virus, encode Class 1 fusion proteins which mediate membrane fusion and viral entry. In this review, we highlight recent advances in the discovery and development of small-molecule entry inhibitors reported over the past five years that target viruses encoding Class 1 fusion proteins.<\/jats:p>","DOI":"10.1021\/acsinfecdis.6c00302","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:17:28Z","timestamp":1785849448000},"page":"2485-2504","source":"Crossref","is-referenced-by-count":1,"title":["Deadbolt Drug\nDiscovery: Locking the Door to Class\n1 Viral Entry by Small Molecules"],"prefix":"10.1021","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0878-7607","authenticated-orcid":true,"given":"John P.","family":"Sloan","sequence":"first","affiliation":[{"name":"University of Illinois Chicago , , , ,","place":["Chicago, Illinois, United States, 60612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago , , , ,","place":["Chicago, Illinois, United States, 60612"]},{"name":"University of Illinois Chicago , , , ,","place":["Chicago, Illinois, United States, 60612"]},{"name":"University of Illinois Chicago , , , ,","place":["Chicago, Illinois, United States, 60612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5410-306X","authenticated-orcid":true,"given":"Terry W.","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago , , , ,","place":["Chicago, Illinois, United States, 60612"]},{"name":"University of Illinois Chicago , , , ,","place":["Chicago, Illinois, United States, 60612"]},{"name":"University of Illinois Chicago , , , ,","place":["Chicago, Illinois, United States, 60612"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"5","key":"2026081410071740800_cit1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00232-020-00136-z","article-title":"Entry Inhibitors: Efficient Means to Block Viral Infection","volume":"253","author":"Pattnaik","year":"2020","journal-title":"J. Membr. Biol."},{"issue":"7","key":"2026081410071740800_cit2","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/biom13071130","article-title":"A Frame-by-Frame Glance at Membrane\nFusion Mechanisms: From Viral Infections to Fertilization","volume":"13","author":"Azimi","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"2026081410071740800_cit3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/v16030332","article-title":"Restriction\nof Viral Glycoprotein\nMaturation by Cellular Protease Inhibitors","volume":"16","author":"Lotke","year":"2024","journal-title":"Viruses"},{"issue":"6","key":"2026081410071740800_cit4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/09687860400017784","article-title":"Class I and\nClass II Viral Fusion Protein Structures\nReveal Similar Principles in Membrane Fusion","volume":"21","author":"Schibli","year":"2004","journal-title":"Mol. Membr. Biol."},{"issue":"1","key":"2026081410071740800_cit5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev-cellbio-101512-122422","article-title":"Virus and\nCell Fusion Mechanisms","volume":"30","author":"Podbilewicz","year":"2014","journal-title":"Annu. Rev. Cell Dev.\nBiol."},{"issue":"3","key":"2026081410071740800_cit6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/10409230802058320","article-title":"Structures\nand Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations\non a Common Theme","volume":"43","author":"White","year":"2008","journal-title":"Crit. Rev. Biochem. Mol.\nBiol."},{"issue":"1469","key":"2026081410071740800_cit7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1098\/rspb.2000.1572","article-title":"The Dependence\nof Viral Parameter Estimates on the Assumed Viral Life Cycle: Limitations\nof Studies of Viral Load Data","volume":"268","author":"Lloyd","year":"2001","journal-title":"Proc. R. Soc.\nLondon B Biol. Sci."},{"issue":"4","key":"2026081410071740800_cit8","first-page":"153","article-title":"Influenza\nA: Understanding the Viral Life Cycle","volume":"82","author":"Samji","year":"2009","journal-title":"Yale\nJ. Biol. Med."},{"issue":"19","key":"2026081410071740800_cit9","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.1073\/pnas.1932511100","article-title":"The Entry of Entry Inhibitors: A Fusion of Science\nand Medicine","volume":"100","author":"Moore","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"2026081410071740800_cit10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2005.06.004","article-title":"Antiviral\nActivity and Mode of Action\nof Caffeoylquinic Acids from Schefflera Heptaphylla (L.) Frodin","volume":"68","author":"Li","year":"2005","journal-title":"Antiviral Res."},{"issue":"1","key":"2026081410071740800_cit11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1021\/acs.jmedchem.4c01646","article-title":"Guardians at the Gate: Optimization\nof Small Molecule\nEntry Inhibitors of Ebola and Marburg Viruses","volume":"68","author":"Argade","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026081410071740800_cit12","doi-asserted-by":"publisher","first-page":"117679","DOI":"10.1016\/j.ejmech.2025.117679","article-title":"Refinement\nof Imidazo[2,1-a]Pyrimidines in Pursuit of Potential Drug Candidates\nagainst Group 2 Influenza A Viruses","volume":"292","author":"Argade","year":"2025","journal-title":"Eur. J.\nMed. Chem."},{"issue":"13","key":"2026081410071740800_cit13","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1021\/acs.jmedchem.9b00654","article-title":"Discovery of Ziresovir as a Potent,\nSelective, and Orally Bioavailable Respiratory Syncytial Virus Fusion\nProtein Inhibitor","volume":"62","author":"Zheng","year":"2019","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026081410071740800_cit14","doi-asserted-by":"publisher","first-page":"8297","DOI":"10.1074\/jbc.M111.324483","article-title":"Coiled-Coil\nExtension on Peptide Fusion Inhibitor of HIV-1 Influences Selection\nof Resistance Pathways","volume":"287","author":"Zhuang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2026081410071740800_cit15","doi-asserted-by":"publisher","first-page":"10578","DOI":"10.1038\/s41467-024-54746-5","article-title":"Exploring Distinct Modes of Inter-Spike Cross-Linking\nfor Enhanced Neutralization by SARS-CoV-2 Antibodies","volume":"15","author":"Nan","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"2026081410071740800_cit16","doi-asserted-by":"publisher","first-page":"3687892","DOI":"10.1155\/sci5\/3687892","article-title":"Exploring TMPRSS2 Drug\nTarget to Combat Influenza and Coronavirus Infection","volume":"2025","author":"Baby","year":"2025","journal-title":"Scientifica (Cairo)."},{"issue":"11","key":"2026081410071740800_cit17","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857),\na Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor\nof Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency\nVirus Type 1 Activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"15","key":"2026081410071740800_cit18","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2165\/00003495-200767150-00010","article-title":"Maraviroc","volume":"67","author":"Carter","year":"2007","journal-title":"Drugs"},{"issue":"1","key":"2026081410071740800_cit19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/molecules16010221","article-title":"Targeting Cell Entry of Enveloped\nViruses as an Antiviral Strategy","volume":"16","author":"Teissier","year":"2011","journal-title":"Molecules"},{"issue":"3","key":"2026081410071740800_cit20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/gutjnl-2013-306155","article-title":"Synergy\nof Entry Inhibitors with\nDirect-Acting Antivirals Uncovers Novel Combinations for Prevention\nand Treatment of Hepatitis C","volume":"64","author":"Xiao","year":"2015","journal-title":"Gut"},{"issue":"5","key":"2026081410071740800_cit21","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03331-22","article-title":"Combinations of\nHost- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression\nof SARS-CoV-2","volume":"10","author":"Wagoner","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"6","key":"2026081410071740800_cit22","doi-asserted-by":"publisher","first-page":"e1072","DOI":"10.1016\/S2214-109X(25)00048-8","article-title":"Health-Care Burden\nRelated to Respiratory Syncytial\nVirus in a Resource-Constrained Setting: A Prospective Observational\nStudy","volume":"13","author":"Saha","year":"2025","journal-title":"Lancet Glob. Health"},{"issue":"9","key":"2026081410071740800_cit23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003662","article-title":"Ebola: Ten\nYears Later Lessons Learned and Future Pandemic Preparedness","volume":"4","author":"Kuppalli","year":"2024","journal-title":"PLOS Global Public Health"},{"issue":"9","key":"2026081410071740800_cit24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.tim.2018.05.013","article-title":"Influenza\nVirus","volume":"26","author":"Hutchinson","year":"2018","journal-title":"Trends Microbiol."},{"issue":"5","key":"2026081410071740800_cit26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41579-022-00711-2","article-title":"Characteristics of SARS-CoV-2 and\nCOVID-19","volume":"20","author":"Hu","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"2026081410071740800_cit25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41579-023-01003-z","article-title":"SARS-CoV-2\nBiology and Host Interactions","volume":"22","author":"Steiner","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"issue":"7798","key":"2026081410071740800_cit27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A Pneumonia Outbreak\nAssociated with a New Coronavirus of Probable Bat Origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"2026081410071740800_cit28","unstructured":"World Health Organization.\n          . WHO COVID-19\ndashboard. https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=o (accessed\nNovember 4, 2025)."},{"issue":"21","key":"2026081410071740800_cit29","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell Entry Mechanisms\nof SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc.\nNatl. Acad. Sci. U. S. A."},{"issue":"1","key":"2026081410071740800_cit30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2\nEntry into Cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"2026081410071740800_cit31","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2403","article-title":"Insight into the Role of Clathrin-mediated\nEndocytosis Inhibitors in SARS-CoV-2 Infection","volume":"33","author":"Alkafaas","year":"2023","journal-title":"Rev. Med. Virol."},{"issue":"7902","key":"2026081410071740800_cit32","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 Usage by SARS-CoV-2 Omicron Impacts\nInfectivity and Fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"2026081410071740800_cit33","doi-asserted-by":"publisher","first-page":"1575747","DOI":"10.3389\/fmolb.2025.1575747","article-title":"Broad-Spectrum\nCoronavirus Inhibitors\nDiscovered by Modeling Viral Fusion Dynamics","volume":"12","author":"Reilly","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"2026081410071740800_cit34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12879-024-09468-w","article-title":"Safety and Efficacy\nof Camostat Mesylate for Covid-19: A Systematic Review and Meta-Analysis\nof Randomized Controlled Trials","volume":"24","author":"Khan","year":"2024","journal-title":"BMC Infect.\nDis."},{"issue":"4","key":"2026081410071740800_cit37","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00970-21","article-title":"The TMPRSS2 Inhibitor\nNafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models\nof COVID-19","volume":"12","author":"Li","year":"2021","journal-title":"mBio"},{"issue":"43","key":"2026081410071740800_cit35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108728118","article-title":"A Novel Class of TMPRSS2 Inhibitors\nPotently Block SARS-CoV-2 and MERS-CoV Viral Entry and Protect Human\nEpithelial Lung Cells","volume":"118","author":"Mahoney","year":"2021","journal-title":"Proc. Natl. Acad. Sci.\nU. S. A."},{"issue":"35","key":"2026081410071740800_cit36","doi-asserted-by":"publisher","first-page":"18539","DOI":"10.1039\/D5CP02191J","article-title":"Difference in the Inhibitory Mechanism against TMPRSS2 between Camostat\nand Nafamostat: Implications for Drug Design","volume":"27","author":"Yang","year":"2025","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1","key":"2026081410071740800_cit38","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.1038\/s41467-025-60832-z","article-title":"An Orally Available Mpro\/TMPRSS2\nBispecific Inhibitor with Potent Anti-Coronavirus Efficacy in Vivo","volume":"16","author":"Shuai","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"2026081410071740800_cit39","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41598-025-30881-x","article-title":"Discovery\nof Thiadiazole-Based\nSmall-Molecule Inhibitors of SARS-CoV-2 Spike-ACE2 Interaction through\nIntegrated Computational Prediction and Experimental Validation","volume":"16","author":"Gul","year":"2026","journal-title":"Sci. Rep."},{"issue":"6","key":"2026081410071740800_cit40","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acsinfecdis.1c00070","article-title":"Small-Molecule Inhibitors\nof the Coronavirus Spike: ACE2 Protein\u2013Protein Interaction\nas Blockers of Viral Attachment and Entry for SARS-CoV-2","volume":"7","author":"Bojadzic","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"2026081410071740800_cit41","doi-asserted-by":"publisher","DOI":"10.2210\/pdb6vsb\/pdb","article-title":"Prefusion 2019-NCoV\nSpike Glycoprotein\nwith a Single Receptor-Binding Domain Up","volume":"26","author":"Wrapp","year":"2020","journal-title":"February"},{"key":"2026081410071740800_cit42","doi-asserted-by":"crossref","DOI":"10.2210\/pdb5t6n\/pdb","volume-title":"Crystal Structure\nof the A\/Hong Kong\/1\/1968 (H3N2) Influenza Virus Hemagglutinin in\nComplex with the Antiviral Drug Arbidol","author":"Kadam","year":"2017"},{"key":"2026081410071740800_cit43","doi-asserted-by":"crossref","DOI":"10.2210\/pdb6cf7\/pdb","volume-title":"Crystal Structure\nof the A\/Solomon Islands\/3\/2006(H1N1) Influenza Virus Hemagglutinin\nin Complex with Small Molecule JNJ4796","author":"Kadam","year":"2019"},{"key":"2026081410071740800_cit44","doi-asserted-by":"crossref","DOI":"10.2210\/pdb5jq7\/pdb","volume-title":"Crystal Structure of Ebola Glycoprotein\nin Complex with Toremifene","author":"Zhao","year":"2016"},{"key":"2026081410071740800_cit45","doi-asserted-by":"crossref","DOI":"10.2210\/pdb8ttw\/pdb","volume-title":"Cryo-EM Structure of\nBG505 SOSIP.664 HIV-1 Env Trimer in Complex with Temsavir, 8ANC195,\nand 10\u20131074","author":"Tolbert","year":"2023"},{"key":"2026081410071740800_cit46","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-32-9898-9_7","article-title":"HIV: Biology to Treatment","volume-title":"NanoBioMedicine","author":"Verma","year":"2020"},{"key":"2026081410071740800_cit47","unstructured":"World Health Organization.\n          . HIV WHO. https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids (accessed November 12, 2025)."},{"issue":"2","key":"2026081410071740800_cit48","doi-asserted-by":"publisher","first-page":"S582","DOI":"10.1067\/mai.2003.91","article-title":"13. HIV-1 Infection","volume":"111","author":"Sleasman","year":"2003","journal-title":"Journal\nof Allergy and Clinical Immunology"},{"issue":"1","key":"2026081410071740800_cit49","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV Infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"2026081410071740800_cit50","doi-asserted-by":"publisher","first-page":"a006866","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: Cell\nBinding and Entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect.\nMed."},{"key":"2026081410071740800_cit51","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-0980-9_10","article-title":"Molecular Mechanisms\nof HIV Entry","volume-title":"Viral Molecular Machines","author":"Wilen","year":"2012"},{"issue":"3","key":"2026081410071740800_cit52","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1073\/pnas.0911004107","article-title":"Structure of HIV-1\nGp120 with Gp41-Interactive Region\nReveals Layered Envelope Architecture and Basis of Conformational\nMobility","volume":"107","author":"Pancera","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9581","key":"2026081410071740800_cit53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(07)61052-6","article-title":"HIV Entry Inhibitors","volume":"370","author":"Este\u0301","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"2026081410071740800_cit54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/imr.12507","article-title":"The HIV 1 Envelope Glycoprotein Structure:\nNailing\ndown a Moving Target","volume":"275","author":"Ward","year":"2017","journal-title":"Immunol. Rev."},{"key":"2026081410071740800_cit55","doi-asserted-by":"crossref","DOI":"10.1177\/0018578720985433","volume-title":"Fostemsavir","author":"Craft","year":"2021"},{"issue":"1","key":"2026081410071740800_cit56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12981-024-00646-z","article-title":"HIV Drug Resistance:\nAnalysis of Viral Genotypes and Mutation Loci\nin People Living with HIV in Chongqing, China (2016\u20132023)","volume":"21","author":"Gao","year":"2024","journal-title":"AIDS Res. Ther."},{"issue":"7","key":"2026081410071740800_cit58","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1128\/AAC.00426-12","article-title":"In Vitro Antiviral Characteristics\nof HIV-1 Attachment Inhibitor BMS-626529, the Active Component of\nthe Prodrug BMS-663068","volume":"56","author":"Nowicka-Sans","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026081410071740800_cit59","doi-asserted-by":"publisher","first-page":"100260","DOI":"10.1016\/j.crmicr.2024.100260","article-title":"ADS-J21 Is\na Novel HIV-1 Entry Inhibitor\nTargeting Gp41","volume":"7","author":"Liang","year":"2024","journal-title":"Curr. Res. Microb. Sci."},{"key":"2026081410071740800_cit60","doi-asserted-by":"publisher","first-page":"613361","DOI":"10.3389\/fphar.2020.613361","article-title":"Rational Design\nof A Novel Small-Molecule HIV-1 Inactivator Targeting Both Gp120 and\nGp41 of HIV-1","volume":"11","author":"Pu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"2026081410071740800_cit61","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12879-024-09122-5","article-title":"Mechanism\nof Action, Resistance, Interaction, Pharmacokinetics, Pharmacodynamics,\nand Safety of Fostemsavir","volume":"24","author":"Heidary","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"2026081410071740800_cit62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1021\/acs.jmedchem.7b01337","article-title":"Inhibitors of HIV-1\nAttachment: The Discovery and Development\nof Temsavir and Its Prodrug Fostemsavir","volume":"61","author":"Meanwell","year":"2018","journal-title":"J.\nMed. Chem."},{"issue":"11","key":"2026081410071740800_cit63","doi-asserted-by":"publisher","first-page":"e740","DOI":"10.1016\/S2352-3018(20)30240-X","article-title":"Safety and\nEfficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in\nHeavily Treatment-Experienced Individuals: Week 96 Results of the\nPhase 3 BRIGHTE Study","volume":"7","author":"Lataillade","year":"2020","journal-title":"Lancet HIV"},{"issue":"1","key":"2026081410071740800_cit64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.virol.2005.08.007","article-title":"The Anti-HIV Activity of ADS-J1 Targets\nthe HIV-1 Gp120","volume":"343","author":"Armand-Ugo\u0301n","year":"2005","journal-title":"Virology"},{"issue":"9","key":"2026081410071740800_cit65","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.bmc.2013.02.041","article-title":"CD4Mimics as HIV Entry\nInhibitors: Lead Optimization\nStudies of the Aromatic Substituents","volume":"21","author":"Narumi","year":"2013","journal-title":"Bioorg.\nMed. Chem."},{"issue":"23","key":"2026081410071740800_cit66","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1021\/jm900450n","article-title":"Design, Synthesis, and Structure\u2013Activity Relationship\nof a Novel Series of 2-Aryl 5-(4-Oxo-3-Phenethyl-2-Thioxothiazolidinylidenemethyl)Furans\nas HIV-1 Entry Inhibitors","volume":"52","author":"Katritzky","year":"2009","journal-title":"J. Med. Chem."},{"issue":"7519","key":"2026081410071740800_cit67","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/513481a","article-title":"Chemistry: Chemical\nCon Artists Foil Drug Discovery","volume":"513","author":"Baell","year":"2014","journal-title":"Nature"},{"key":"2026081410071740800_cit68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-38919-1_1","article-title":"Respiratory\nSyncytial Virus: Virology","volume":"372","author":"Collins","year":"2013","journal-title":"Reverse Genetics,\nand Pathogenesis of Disease"},{"key":"2026081410071740800_cit69","unstructured":"World Health Organization.\n          . Respiratory\nsyncytial virus (RSV)\n- WHO. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/respiratory-syncytial-virus-(rsv) (accessed June 30, 2026)."},{"issue":"3","key":"2026081410071740800_cit70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.37201\/req\/006.2024","article-title":"Microbiological and Epidemiological Features of Respiratory\nSyncytial Virus","volume":"37","author":"Sanz-Mun\u0303oz","year":"2024","journal-title":"Revista Espan\u0303ola de\nQuimioterapia"},{"issue":"12","key":"2026081410071740800_cit71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005318","article-title":"Respiratory Syncytial\nVirus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial\nCultures","volume":"11","author":"Johnson","year":"2015","journal-title":"PLoS Pathog"},{"issue":"7817","key":"2026081410071740800_cit72","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-020-2369-7","article-title":"IGF1R Is an Entry\nReceptor for Respiratory Syncytial Virus","volume":"583","author":"Griffiths","year":"2020","journal-title":"Nature"},{"issue":"9","key":"2026081410071740800_cit73","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1007\/s12325-022-02256-5","article-title":"Ribavirin for Treatment of Subjects\nwith Respiratory Syncytial Virus-Related Infection: A Systematic Review\nand Meta-Analysis","volume":"39","author":"Tejada","year":"2022","journal-title":"Adv. Ther."},{"issue":"2","key":"2026081410071740800_cit74","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/tid.12510","article-title":"Current Practices\nfor Treatment of\nRespiratory Syncytial Virus and Other Non-influenza Respiratory Viruses\nin High-risk Patient Populations: A Survey of Institutions in the\nMidwestern Respiratory Virus Collaborative","volume":"18","author":"Beaird","year":"2016","journal-title":"Transplant Infectious Disease"},{"issue":"9","key":"2026081410071740800_cit75","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01385-24","article-title":"A New Mechanism of Respiratory Syncytial Virus Entry Inhibition by\nSmall-Molecule to Overcome K394R-Associated Resistance","volume":"15","author":"Song","year":"2024","journal-title":"mBio"},{"issue":"3","key":"2026081410071740800_cit76","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1096\/fj.201800579R","article-title":"Small Molecule Inhibits\nRespiratory Syncytial Virus Entry and Infection by Blocking the Interaction\nof the Viral Fusion Protein with the Cell Membrane","volume":"33","author":"Tang","year":"2019","journal-title":"FASEB J."},{"key":"2026081410071740800_cit77","doi-asserted-by":"publisher","first-page":"1393511","DOI":"10.3389\/fmicb.2024.1393511","article-title":"Emodin Inhibits Respiratory Syncytial Virus Entry by Interactions\nwith Fusion Protein","volume":"15","author":"Xiong","year":"2024","journal-title":"Front. Microbiol."},{"issue":"1","key":"2026081410071740800_cit78","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41392-024-01858-5","article-title":"Farnesyltransferase\nInhibitor Lonafarnib Suppresses Respiratory Syncytial Virus Infection\nby Blocking Conformational Change of Fusion Glycoprotein","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"2026081410071740800_cit79","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ptr.5631","article-title":"A Review of Its Pharmacology, Toxicity\nand Pharmacokinetics","volume":"30","author":"Dong","year":"2016","journal-title":"Phytotherapy Research"},{"issue":"2","key":"2026081410071740800_cit80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40265-020-01464-z","article-title":"Lonafarnib:\nFirst Approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"issue":"11","key":"2026081410071740800_cit81","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1093\/cid\/ciz1167","article-title":"A Phase\n2b, Randomized, Double-Blind, Placebo-Controlled Multicenter Study\nEvaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability\nof Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory\nSyncytial Virus Infection of the Lower Respiratory Tract","volume":"71","author":"Marty","year":"2020","journal-title":"Clinical Infectious Diseases"},{"key":"2026081410071740800_cit82","unstructured":"Pfizer.\n          \n          Study to Learn\nAbout the Amount of the Study Medicine (Sisunatovir) in Blood and\nIts Safety in Infants and Children With Pneumonia Caused by RSV. https:\/\/clinicaltrials.gov\/study\/NCT06102174 (accessed November 10, 2025)."},{"issue":"5","key":"2026081410071740800_cit83","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S2352-4642(25)00067-7","article-title":"Efficacy and\nSafety of Ziresovir in Hospitalised Infants Aged 6 Months or Younger\nwith Respiratory Syncytial Virus Infection in China: Findings from\na Phase 3 Randomised Trial with 24-Month Follow-Up","volume":"9","author":"Zhang","year":"2025","journal-title":"Lancet Child Adolesc. Health"},{"issue":"12","key":"2026081410071740800_cit84","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2313551","article-title":"Ziresovir in Hospitalized\nInfants with Respiratory Syncytial Virus Infection","volume":"391","author":"Zhao","year":"2024","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"2026081410071740800_cit85","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A Brief Review\nof Influenza Virus Infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J. Med. Virol."},{"issue":"6","key":"2026081410071740800_cit86","doi-asserted-by":"publisher","first-page":"112549","DOI":"10.1016\/j.isci.2025.112549","article-title":"Cell-Based Sialoglycan Arrays for Directly Comparing Influenza A\nVirus Receptor Requirements for Binding and Infection","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"issue":"33","key":"2026081410071740800_cit87","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1073\/pnas.0803711105","article-title":"Epsin 1 Is a Cargo-Specific\nAdaptor for the Clathrin-Mediated\nEndocytosis of the Influenza Virus","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl.\nAcad. Sci. U. S. A."},{"key":"2026081410071740800_cit88","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","article-title":"Viral Membrane\nFusion","volume":"479\u2013480","author":"Harrison","year":"2015","journal-title":"Virology"},{"issue":"21","key":"2026081410071740800_cit89","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00649-19","article-title":"TMPRSS2 Is\nthe Major Activating Protease\nof Influenza A Virus in Primary Human Airway Cells and Influenza B\nVirus in Human Type II Pneumocytes","volume":"93","author":"Limburg","year":"2019","journal-title":"J. Virol."},{"key":"2026081410071740800_cit90","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol\nas a Broad-Spectrum Antiviral:\nAn Update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res."},{"issue":"7","key":"2026081410071740800_cit91","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza\nand Antiviral Resistance: An Overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"European\nJournal of Clinical Microbiology & Infectious Diseases"},{"issue":"10","key":"2026081410071740800_cit92","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.1021\/acs.jmedchem.1c02013","article-title":"Discovery of Pentacyclic\nTriterpenoid PROTACs as a Class of Effective Hemagglutinin Protein\nDegraders","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026081410071740800_cit93","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/jmv.22234","article-title":"Antiviral Activity\nof Arbidol, a Broad-spectrum Drug for Use against Respiratory Viruses,\nVaries According to Test Conditions","volume":"84","author":"Brooks","year":"2012","journal-title":"J. Med.\nVirol."},{"key":"2026081410071740800_cit94","doi-asserted-by":"publisher","first-page":"114906","DOI":"10.1016\/j.ejmech.2022.114906","article-title":"Optimization and SAR Research at the Benzoxazole and\nTetrazole Rings of JNJ4796 as New Anti-Influenza A Virus Agents, Part\n2","volume":"245","author":"Wu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"2026081410071740800_cit95","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1038\/s41401-024-01331-7","article-title":"Small Molecule\nCompound Targeting Hemagglutinin Inhibits\nInfluenza A Virus and Exhibits Broad-Spectrum Antiviral Activity","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"2026081410071740800_cit96","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk9004","article-title":"An Orally\nActive Entry Inhibitor of Influenza A Viruses Protects\nMice and Synergizes with Oseltamivir and Baloxavir Marboxil","volume":"10","author":"Gaisina","year":"2024","journal-title":"Sci. Adv."},{"key":"2026081410071740800_cit97","doi-asserted-by":"publisher","first-page":"113591","DOI":"10.1016\/j.ejmech.2021.113591","article-title":"Optimization and SAR Research at\nthe Piperazine and Phenyl Rings of JNJ4796 as New Anti-Influenza A\nVirus Agents, Part 1","volume":"222","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"6431","key":"2026081410071740800_cit98","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6221","article-title":"A Small-Molecule Fusion Inhibitor of Influenza Virus\nIs Orally Active in Mice","volume":"363","author":"van Dongen","year":"2019","journal-title":"Science (1979)"},{"issue":"20","key":"2026081410071740800_cit99","doi-asserted-by":"publisher","first-page":"14104","DOI":"10.1021\/acs.jmedchem.2c01329","article-title":"Synthesis,\nOptimization, and Structure\u2013Activity\nRelationships of Imidazo[1,2- a ]Pyrimidines as Inhibitors\nof Group 2 Influenza A Viruses","volume":"65","author":"Alqarni","year":"2022","journal-title":"J. Med. Chem."},{"issue":"33","key":"2026081410071740800_cit100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2503899122","article-title":"Mechanistic Insights\ninto the Small-Molecule Inhibition of Influenza A Virus Entry","volume":"122","author":"Xu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026081410071740800_cit101","unstructured":"World Health Organization.\n          . Ebola Disease\n- WHO. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-disease (accessed November 4, 2025)."},{"issue":"2","key":"2026081410071740800_cit102","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.molmed.2015.12.005","article-title":"Progression of Ebola\nTherapeutics During the 2014\u20132015 Outbreak","volume":"22","author":"Mendoza","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"4","key":"2026081410071740800_cit103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004731","article-title":"Ebola Virus Entry: A Curious and\nComplex Series of Events","volume":"11","author":"Moller-Tank","year":"2015","journal-title":"PLoS Pathog"},{"key":"2026081410071740800_cit104","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-981-16-8702-0_10","article-title":"Ebola Virus Entry Inhibitors","volume":"1366","author":"Du","year":"2022","journal-title":"Adv. Exp. Med.\nBiol."},{"issue":"1","key":"2026081410071740800_cit105","doi-asserted-by":"publisher","first-page":"41226","DOI":"10.1038\/srep41226","article-title":"Selective Inhibition\nof Ebola Entry with Selective Estrogen Receptor Modulators by Disrupting\nthe Endolysosomal Calcium","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"issue":"190","key":"2026081410071740800_cit106","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-Approved Selective Estrogen\nReceptor Modulators Inhibit Ebola Virus Infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2026081410071740800_cit107","doi-asserted-by":"publisher","first-page":"106167","DOI":"10.1016\/j.antiviral.2025.106167","article-title":"Mechanisms of Action\nof Repurposed Ebola Virus Antivirals \u2013 the Roles of Phospholipidosis\nand Cholesterol Homeostasis","volume":"238","author":"Kelly","year":"2025","journal-title":"Antiviral Res."},{"issue":"1","key":"2026081410071740800_cit108","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41467-023-44504-4","article-title":"Tubeimosides\nAre Pan-Coronavirus and Filovirus Inhibitors That Can Block Their\nFusion Protein Binding to Niemann-Pick C1","volume":"15","author":"Khan","year":"2024","journal-title":"Nat.\nCommun."},{"issue":"7610","key":"2026081410071740800_cit109","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene Interacts with and Destabilizes\nthe Ebola Virus Glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"issue":"18","key":"2026081410071740800_cit110","doi-asserted-by":"publisher","first-page":"16381","DOI":"10.1021\/acs.jmedchem.4c01267","article-title":"Discovery of Thiophene Derivatives\nas Potent, Orally Bioavailable, and Blood\u2013Brain Barrier-Permeable\nEbola Virus Entry Inhibitors","volume":"67","author":"Morales-Tenorio","year":"2024","journal-title":"J. Med. Chem."},{"issue":"16","key":"2026081410071740800_cit111","doi-asserted-by":"publisher","first-page":"13737","DOI":"10.1021\/acs.jmedchem.4c00527","article-title":"N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum\nFiloviral Entry Inhibitors","volume":"67","author":"Durante","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026081410071740800_cit112","doi-asserted-by":"publisher","first-page":"1244317","DOI":"10.3389\/fphar.2023.1244317","article-title":"MBC and ECBL\nLibraries: Outstanding Tools for Drug Discovery","volume":"14","author":"Ginex","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"13","key":"2026081410071740800_cit113","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.1021\/acs.jmedchem.0c00463","article-title":"Discovery and Structural\nOptimization of 4-(Aminomethyl)Benzamides\nas Potent Entry Inhibitors of Ebola and Marburg Virus Infections","volume":"63","author":"Gaisina","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026081410071740800_cit114","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211930","article-title":"Lassa\nVirus Glycoprotein Complex Review: Insights into Its Unique Fusion\nMachinery","volume":"42","author":"Pennington","year":"2022","journal-title":"Biosci. Rep."},{"issue":"1","key":"2026081410071740800_cit115","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12879-021-05837-x","article-title":"Infection\nPattern, Case Fatality\nRate and Spread of Lassa Virus in Nigeria","volume":"21","author":"Yaro","year":"2021","journal-title":"BMC\nInfect. Dis."},{"issue":"4","key":"2026081410071740800_cit116","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01902-16","article-title":"Lassa Virus Cell Entry\nReveals New Aspects of Virus-Host Cell Interaction","volume":"91","author":"Torriani","year":"2017","journal-title":"J. Virol."},{"issue":"1","key":"2026081410071740800_cit117","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/pathogens8010017","article-title":"Virus\u2013Host\nInteractions Involved in Lassa Virus Entry and Genome Replication","volume":"8","author":"Loureiro","year":"2019","journal-title":"Pathogens"},{"issue":"1","key":"2026081410071740800_cit118","doi-asserted-by":"publisher","first-page":"19911","DOI":"10.1038\/s41598-022-23760-2","article-title":"Lassa Antiviral\nLHF-535 Protects Guinea Pigs from Lethal\nChallenge","volume":"12","author":"Cashman","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"2026081410071740800_cit119","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00951-22","article-title":"Safety\nand Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever,\nin Healthy Adults","volume":"66","author":"Amberg","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"2026081410071740800_cit120","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.antiviral.2011.02.012","article-title":"Evaluation of Lassa Antiviral Compound\nST-193 in a Guinea Pig Model","volume":"90","author":"Cashman","year":"2011","journal-title":"Antiviral Res."},{"issue":"7","key":"2026081410071740800_cit121","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00714-24","article-title":"An Estrogen Receptor Agonist, Inhibits\nLassa Virus\nEntry","volume":"98","author":"Zhang","year":"2024","journal-title":"J. Virol."},{"key":"2026081410071740800_cit122","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0009-2797(85)80125-3","article-title":"Carcinogenicity\nand Metabolic Activation of Hexestrol","volume":"55","author":"Liehr","year":"1985","journal-title":"Chem.\nBiol. Interact."},{"issue":"3","key":"2026081410071740800_cit123","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2024.12.021","article-title":"Structural and Functional\nAnalysis\nof the Nipah Virus Polymerase Complex","volume":"188","author":"Hu","year":"2025","journal-title":"Cell"},{"issue":"6","key":"2026081410071740800_cit124","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1128\/JVI.02696-12","article-title":"Nipah Virus Entry and Egress from Polarized Epithelial\nCells","volume":"87","author":"Lamp","year":"2013","journal-title":"J. Virol."},{"issue":"6","key":"2026081410071740800_cit125","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/microorganisms10061181","article-title":"Computational Identification\nof Potential Multitarget Inhibitors of Nipah Virus by Molecular Docking\nand Molecular Dynamics","volume":"10","author":"Randhawa","year":"2022","journal-title":"Microorganisms"},{"issue":"2","key":"2026081410071740800_cit126","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s11030-023-10624-8","article-title":"Evaluation\nof the Interaction between\nPotent Small Molecules against the Nipah Virus Glycoprotein in Malaysia\nand Bangladesh Strains, Accompanied by the Human Ephrin-B2 and Ephrin-B3\nReceptors; a Simulation Approach","volume":"28","author":"Ebrahimi","year":"2024","journal-title":"Mol. Divers."}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.6c00302","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/12\/8\/2485\/66330571\/acsinfecdis.6c00302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/12\/8\/2485\/66330571\/acsinfecdis.6c00302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:16:59Z","timestamp":1786717019000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article\/12\/8\/2485\/5236757\/Deadbolt-Drug-Discovery-Locking-the-Door-to-Class"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":125,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,29]]},"published-print":{"date-parts":[[2026,8,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.6c00302","relation":{},"ISSN":["2373-8227"],"issn-type":[{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}